Thursday, September 24, 2015

By Tom Philpott Thirty-one House members, most of whom, public records show, got campaign dollars from compound drug lobbyists, are pressing the Defense Department to soften rules set in May that block TRICARE coverage of compound medicines when medical efficacy is unproven or prices extreme.

No comments: